Alto Neuroscience, Inc. (ANRO) — Net Asset Quality Index
Alto Neuroscience, Inc. (ANRO) has a Net Asset Quality Index of 81.8% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $184.69 Million minus total liabilities of $33.55 Million yields net assets of $151.14 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read total liabilities of Alto Neuroscience, Inc. for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Alto Neuroscience, Inc. Net Asset Quality Index Over Time (2021–2025)
This chart shows how Alto Neuroscience, Inc.'s Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 81.8%, representing net assets of $151.14 Million against total assets of $184.69 Million USD. For live market cap and overall valuation, see ANRO market cap.
Annual Net Asset Quality Index for Alto Neuroscience, Inc. (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for Alto Neuroscience, Inc. from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See ANRO net asset value for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 81.8% | $151.14 Million | $184.69 Million | $33.55 Million | ▼ -3.5 pp |
| 2024 | 85.3% | $151.46 Million | $177.54 Million | $26.08 Million | ▲ +168.0 pp |
| 2023 | -82.7% | $-71.67 Million | $86.63 Million | $158.30 Million | ▼ -7.2 pp |
| 2022 | -75.5% | $-38.41 Million | $50.85 Million | $89.26 Million | ▼ -32.2 pp |
| 2021 | -43.3% | $-12.48 Million | $28.79 Million | $41.27 Million | — |